ALK – Financial calendar for the 2026 financial year

Company Overview - ALK is a global specialty pharmaceutical company focused on allergy and allergic asthma treatments, offering allergy immunotherapy and related products and services [2] - The company is headquartered in Hørsholm, Denmark, and employs approximately 2,800 people worldwide [2] Financial Calendar - The financial calendar for ALK includes key dates such as: - 23 January 2026: Silent period begins - 20 February 2026: Annual report for 2025 is scheduled for release - 16 March 2026 at 4:00 p.m.: Annual General Meeting [4] - Additional reporting dates include: - 5 May 2026: Three-month interim report (Q1) for 2026 - 20 August 2026: Six-month interim report (Q2) for 2026 - 18 November 2026: Nine-month interim report (Q3) for 2026 [5] AGM Participation - Written requests for specific business transactions to be included in the AGM agenda must be received by the company by 30 January 2026 [1]